Beta-thalassemia overview: Difference between revisions

	Beta-thalassemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Beta-thalassemia from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Beta-thalassemia overview On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Beta-thalassemia overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Beta-thalassemia overview
CDC on Beta-thalassemia overview
Beta-thalassemia overview in the news
Blogs on Beta-thalassemia overview
Directions to Hospitals Treating Beta-thalassemia
Risk calculators and risk factors for Beta-thalassemia overview

Revision as of 22:44, 21 August 2023

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Beta-thalassemia}}
-{{CMG}}
+{{CMG}}; {{AE}} {{MHP}}
 ==Overview==
-'''Beta-thalassemia''' (β-thalassemia) is a form of [[thalassemia]] due to mutations in the [[HBB]] gene on [[chromosome 11]] <ref>{{OMIM|141900}}</ref>, inherited in an [[autosomal recessive]] fashion.
-==References==
 {{reflist|2}}